EUVIMEDEUVIMED entdecken
Crossref

How Can Radiopharmaceutical Therapies Reach Their Full Potential? Improving Dose Reporting and Phase I Clinical Trial Design

Ana P Kiess iD, Joseph O'Donoghue, Carlos Uribe, Lisa Bodei, Robert F Hobbs, Jacob Hesterman iD, Adam L Kesner iD, George Sgouros, RPT-TEC group

Journal of Clinical Oncology · 20.05.2024 · 42 (15) · 1734-1737

DOI: 10.1200/jco.23.01241 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Oncology, erschienen am 20.05.2024. Verfasst von Ana P Kiess und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Baltimore, MD. Hauptthemen laut MEDLINE: Clinical Trials, Phase I as Topic, Radiopharmaceuticals. Die Arbeit wurde bisher 39-mal zitiert (Crossref) und nennt 33 Literaturangaben. Gefördert von: NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Clinical Trials, Phase I as TopicRadiopharmaceuticalsHumansResearch DesignNeoplasms

Substanzen

Radiopharmaceuticals

Autor:innen und Institutionen

  • Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Baltimore, MD.
  • Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, NY.
  • Functional Imaging, BC Cancer, Vancouver, BC, Canada.
  • Department of Radiology, University of British Columbia, Vancouver, BC, Canada.
  • Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY.
  • Ratio Therapeutics, Inc, Boston, MA.

ORCID-Profile: Ana P Kiess, Jacob Hesterman, Adam L Kesner

Förderung

  • NCI NIH HHS

Zitieren

APA

Kiess, A. P., O'Donoghue, J., Uribe, C., Bodei, L., Hobbs, R. F., Hesterman, J., Kesner, A. L., Sgouros, G., & RPT-TEC group (2024). How Can Radiopharmaceutical Therapies Reach Their Full Potential? Improving Dose Reporting and Phase I Clinical Trial Design. Journal of Clinical Oncology, 42(15), 1734-1737. https://doi.org/10.1200/jco.23.01241

Vancouver

Kiess AP, O'Donoghue J, Uribe C, Bodei L, Hobbs RF, Hesterman J, et al. How Can Radiopharmaceutical Therapies Reach Their Full Potential? Improving Dose Reporting and Phase I Clinical Trial Design. Journal of Clinical Oncology. 2024;42(15):1734-1737. doi:10.1200/jco.23.01241

BibTeX
@article{Kiess2024,
  author = {Kiess, Ana P and O'Donoghue, Joseph and Uribe, Carlos and Bodei, Lisa and Hobbs, Robert F and Hesterman, Jacob and Kesner, Adam L and Sgouros, George and RPT-TEC group, RPT-TEC group},
  title = {How Can Radiopharmaceutical Therapies Reach Their Full Potential? Improving Dose Reporting and Phase I Clinical Trial Design},
  journal = {Journal of Clinical Oncology},
  year = {2024},
  volume = {42},
  number = {15},
  pages = {1734--1737},
  doi = {10.1200/jco.23.01241}
}
Kostenlos starten →